EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic Value of Claims Data for Chronic Kidney Disease-Associated Health Risks

Sebastian Schwab, Volquart Stoy, Olga Dortmann, Janika Raudzus, Thomas Mayrhofer, Sibylle von Vietinghoff

Kidney and Blood Pressure Research · 2026

DOI: 10.1159/000553419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2026. Verfasst von Sebastian Schwab und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Section, Medical Clinic 1, University Hospital Bonn, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, sebastian.schwab@ukbonn…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) associates with kidney failure and overall health risks. We here investigated the prognostic value of claims data in the absence of biochemical data.

Methods

A total of 29,144 persons insured at AOK Rhineland-Hamburg with a diagnosis of CKDIII or CKDIV in 2016 were included in analyses of renal replacement therapy (rRT), death, hospital admissions and diagnoses, and prescription of CKD-related therapies during the ensuing 6-year period (2017–2022) using corresponding billing codes.

Results

In 22,228 individuals diagnosed with CKDIII and 6,916 with CKDIV during the base year, rRT was prescribed in 3.8% and 14.3% during the observation period; 7.0% and 13.3% were admitted to the hospital for acute kidney injury (AKI). A combination of claims data significantly contributed to the prognosis of rRT (AUC 0.87) and AKI (AUC 0.68) and overall outcomes, death (AUC 0.97), hospital admission for heart failure (AUC 0.76), and intensive care unit (ICU) therapy (AUC 0.67). All AUCs significantly improved after inclusion of CKD stage into the model. Outpatient prescriptions of renin-angiotensin system and sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with significantly better renal and cardiovascular outcomes. Prescription of CKD-related pharmacotherapy for calcium metabolism (AUC 0.74), hyperkalemia/hyperphosphatemia (AUC 0.83), metabolic acidosis (AUC 0.81), erythropoiesis-stimulating agents (AUC 0.65), and hyperuricemia therapy (AUC 0.72) was prognosticated by claims data with significant contribution of CKD stage. Summary and Conclusion: Claims data provide prognostic information for renal and overall outcomes in CKDIII and CKDIV patients even in the absence of laboratory measurements. Inclusion of additional values should be evaluated in patients with and without CKD for individualized risk calibration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicHumansPrognosisMaleFemaleRenal Replacement TherapyMiddle AgedAgedAcute Kidney InjuryRisk Factors

Stichwörter der Autor:innen

Chronic kidney disease morbidityClaims dataRisk assessment

Autor:innen und Institutionen

  • Nephrology Section, Medical Clinic 1, University Hospital Bonn, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany, sebastian.schwab@ukbonn.de.
  • AOK Rhineland-Hamburg, Duesseldorf, Germany.
  • Center for Preventive Medicine and Digital Health (CPD), Medical Faculty Mannheim - Heidelberg University, Mannheim, Germany.
  • Nephrology Section, Medical Clinic 1, University Hospital Bonn, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany.

Zitieren

APA

Schwab, S., Stoy, V., Dortmann, O., Raudzus, J., Mayrhofer, T., & von Vietinghoff, S. (2026). Prognostic Value of Claims Data for Chronic Kidney Disease-Associated Health Risks. Kidney and Blood Pressure Research. https://doi.org/10.1159/000553419

Vancouver

Schwab S, Stoy V, Dortmann O, Raudzus J, Mayrhofer T, von Vietinghoff S. Prognostic Value of Claims Data for Chronic Kidney Disease-Associated Health Risks. Kidney and Blood Pressure Research. 2026. doi:10.1159/000553419

BibTeX
@article{Schwab2026,
  author = {Schwab, Sebastian and Stoy, Volquart and Dortmann, Olga and Raudzus, Janika and Mayrhofer, Thomas and von Vietinghoff, Sibylle},
  title = {Prognostic Value of Claims Data for Chronic Kidney Disease-Associated Health Risks},
  journal = {Kidney and Blood Pressure Research},
  year = {2026},
  doi = {10.1159/000553419}
}
Kostenlos starten →